“Amphion Innovations has successfully rolled-over its CPNs” says Northland Capital

Convertible Promissory Note Extended to December 2017

  • Amphion announced that the holders of £5,707,738 Convertible Promissory Notes (CPNs) previously due on 31 December 2015 unanimously agreed to amend the terms of the Notes.
  • The Notes will now be redeemed on 31 December 2017 (subject to certain early partial redemptions options) unless previously converted; will be convertible into fully paid ordinary shares of 1 pence in the capital of the Company (Shares) at 8 pence per Share; and will pay interest at 7 per cent. if the respective Noteholder elects to be paid in Ordinary Shares, or will pay interest at 5 per cent. if the respective Noteholder elects to be paid in cash or additional Notes, until conversion or redemption.  In addition, for every £1 of Note held, the respective Noteholder will be issued two warrants.  Each warrant granted will entitle the holder to subscribe for Shares at 10 pence per Share.

Northland Capital partners view: Amphion has successfully rolled-over its CPNs. In so doing the group has further strengthened its balance sheet. We believe that the group’s significant stakes in both Motif Bio plc and Kromek Group plc, are not reflected in the company’s share price.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    amphion innovations

    More articles like this

    amphion innovations

    Sole source supplier contract from DARPA for Kromek PLC

      Further to the announcement of 8 October 2015, Kromek, a radiation detection technology company focusing on the medical, security and nuclear markets, has told DirectorsTalk that the Defense Advanced Research Projects Agency (DARPA), an agency

    amphion innovations

    Amphion Innovations plc $3m draw-down

    Amphion Innovations plc (LSE: AMP), the developer of medical, life science, and technology businesses, today told DirectorsTalk that the Company has agreed terms for the draw-down of an additional tranche of US $3 million under the